TomoTherapy appoints Greish to board

TriMed Staff | | Health Imaging | Artificial Intelligence

TomoTherapy has appointed John J. Greisch to its board of directors, effective Jan. 31.

Greisch will replace Michael J. Cudahy, 83, founder and former CEO of Marquette Medical Systems, is retiring from the TomoTherapy board of directors on Jan. 31, to pursue philanthropic activities.

Greisch has 30 years of corporate finance and operational experience, and currently serves as corporate vice president and president for Baxter International. 

TriMed Staff

Related Content

Deep learning-based reconstructions nearly halve acquisition time of spinal MRIs
Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.